Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 705
Selected: 0
NCT IDTitle
NCT05342493Specified Drug Use Survey on AJOVY Subcutaneous Injection for Long-term Use
NCT01870999A Multiple Dose Safety, Tolerability and Pharmacokinetics Study in Adult Patients With Schizophrenia Following Administration of Aripiprazole IM Depot
NCT01349010Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia
NCT04812379Specified Drug-use Survey on Abilify Prolonged Release Aqueous Suspension for IM Injection (Prevention of Relapse of Mood Episodes in BP)
NCT04784442A Dose-finding Trial of ETC-1002(Bempedoic Acid) in Patients With Hypercholesterolemia
NCT01737931A Trial to Explore Symptomatic Therapy for Application Site Reaction to SPM962 in Healthy Subject
NCT01942161A Short Treatment Study of Aripiprazole in Pediatric Patients With Schizophrenia
NCT02964273Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT00097266Study of Aripiprazole in Patients With Acute Bipolar Mania
NCT04049825A Phase 1 Trial of OPB-111077 in Combination With Bendamustine and Rituximab in Patients With r/r DLBCL
NCT01095016A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma Patients
NCT03892889A Trial in Adult Participants With Schizophrenia Treated Prospectively for 6-months With Abilify MyCite®
NCT01076478Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the Philippines
NCT00048776Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon
NCT07759154A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation
NCT04186403Evaluating the Safety and Tolerability of Brexpiprazole in the Treatment of Adults With Borderline Personality Disorder (BPD)
NCT00545142Abilify in Bipolar Disorder for 6 Weeks Treatment Effectiveness
NCT07786454A Trial of the Safety and Tolerability of SEP-363856 in Adults With Generalized Anxiety Disorder
NCT01739829Open-label Investigation of the Safety and Effectiveness of DIABECELL® in Patients With Type 1 Diabetes Mellitus
NCT06971731A Study of JNT-517 in Participants With Phenylketonuria (PKU)
NCT07486895Trial to Demonstrate the Equivalence of Two Different Strengths of Oral Centanafadine Capsules in Healthy Subjects
NCT03287505Aripiprazole IM Depot for Chinese Patients With Schizophrenia
NCT01509053Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT01488266Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder
NCT00797966Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
NCT00805454Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712
NCT07549581A Study of SEP-380135 in Adults With Schizophrenia or Major Depressive Episode
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT02449044International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia
NCT00201955Study of Rebamipide Eye Drops to Treat Dry Eye
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT01456897A Long-term Trial of OPC-34712 in Patients With Schizophrenia
NCT01423903Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced Cancer
NCT05504486Open-label Brexpiprazole fMRI Trial in Adults With Major Depressive Disorder and Anxiety
NCT04174170Brexpiprazole as Combination Therapy With Sertraline in the Treatment of Adults With Post-traumatic Stress Disorder
NCT01346865Drug-Eluting Stenting Followed by Cilostazol tREAtment Reduces SErious Adverse Cardiac Events (DECREASE-PCI)
NCT03949894Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease
NCT03661983Trial to Evaluate the Long-term Efficacy of Oral Aripiprazole in the Treatment of Pediatric Participants With Tourette's Disorder
NCT01084551Study of SPM 962 in Patients With Restless Legs Syndrome (RLS)
NCT00955812STAT3 Inhibitor for Solid Tumors
NCT00002131A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma
NCT01876381A Phase 2, Multi-center, Open-label, Dose-finding Trial to Investigate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of OPC-41061 in Patients With Chronic Renal Failure Undergoing Hemodialysis or Hemodiafiltration
NCT01801930A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
NCT01424670Safety and Efficacy Trial of Delamanid for 6 Months in Participants With Multidrug-resistant Tuberculosis
NCT01944969Long-term Safety and Tolerability Study of Brexpiprazole as Adjunctive Treatment in Patients With Major Depressive Disorder
NCT01683058Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
NCT00092508CORE: A Study of OPC-6535 With Asacol® in Maintaining Ulcerative Colitis (UC) Remission
NCT02473393A Clinical Trial to Assess Three Different Doses of OPS-2071 in Patients With Bacterial Enteritis
NCT07173478A Phase 3 Trial to Demonstrate the Superiority of 1% OPA-15406 Foam to the Vehicle in Adult Patients With Atopic Dermatitis